Table 2 Stratified analysis of stage of hypertension or age on cardiovascular mortality and all-cause mortality

Man, stratified by age groups

Stage1

60–69

14,677

557(4.64)

1(reference)

1(reference)

1665(13.87)

1(reference)

1(reference)

Stage2

10,921

395(4.54)

0.99(0.87–1.12)

1.01(0.93–1.11)

1167(13.4)

0.97(0.90–1.05)

1.01(0.96–1.07)

Stage3

4,873

306(7.87)

1.71(1.49–1.97)

1.56(1.41–1.72)

710(18.27)

1.33(1.21–1.45)

1.29(1.21–1.37)

Stage1

70–85

14,064

2411(22.82)

1(reference)

1(reference)

5502(52.09)

1(reference)

1(reference)

Stage2

9,956

1727(23.57)

1.04(0.98–1.11)

1.05(0.98–1.13)

3855(52.61)

1.02(0.97–1.06)

1.02(0.97–1.07)

Stage3

4,400

937(29.44)

1.31(1.21–1.41)

1.25(1.14–1.36)

1910(60.02)

1.16(1.10–1.23)

1.13(1.06–1.20)

Man, stratified by hypertension stages: age 60–69 as reference group

Stage1

70–85

14,064

2411(22.82)

4.99(4.55–5.47)

4.52(4.19–4.87)

5502(52.09)

3.80(3.60–4.01)

3.56(3.40–3.74)

Stage2

70–85

9,956

1727(23.57)

5.26(4.71–5.86)

4.55(4.16–4.98)

3855(52.61)

3.97(3.72–4.24)

3.61(3.41–3.82)

Stage3

70–85

4,400

937(29.44)

3.82(3.35–4.34)

3.53(3.14–3.97)

1910(60.02)

3.34(3.06–3.64)

3.13(2.89–3.39)

Stage1

age(continuous)

28,741

2968(13.15)

1.15(1.14–1.16)

1.15(1.14–1.16)

7167(31.76)

1.12(1.12–1.13)

1.12(1.12–1.13)

Stage2

20,877

2122(13.23)

1.15(1.14–1.16)

1.15(1.14–1.15)

5022(31.32)

1.13(1.12–1.13)

1.12(1.12–1.13)

Stage3

9273

1243(17.59)

1.12(1.11–1.13)

1.12(1.11–1.13)

2620(37.07)

1.11(1.10–1.12)

1.11(1.10–1.11)

Women, stratified by age groups

Stage1

60–69

17,112

359(2.44)

1(reference)

1(reference)

1094(7.44)

1(reference)

1(reference)

Stage2

10,480

242(2.75)

1.14(0.97–1.34)

1.11(1.01–1.22)

671(7.64)

1.04(0.94–1.14)

1.05(0.98–1.11)

Stage3

4,293

151(4.12)

1.68(1.39–2.04)

1.48(1.32–1.67)

354(9.65)

1.30(1.15–1.46)

1.29(1.19–1.40)

Stage1

70–85

18,366

3095(21.28)

1(reference)

1(reference)

5917(40.68)

1(reference)

1(reference)

Stage2

11,552

1958(21.72)

1.03(0.97–1.09)

0.99(0.93–1.06)

3589(39.81)

0.98(0.94–1.02)

0.95(0.90–0.99)

Stage3

5,284

1026(25.11)

1.19(1.11–1.27)

1.19(1.10–1.29)

1816(44.44)

1.10(1.04–1.16)

1.08(1.01–1.15)

Women, stratified by hypertension stages: age 60–69 as reference group

Stage1

70–85

18,366

3095(21.28)

8.91(7.99–9.94)

5.97(5.54–6.43)

5917(40.68)

5.56(5.21–5.93)

4.39(4.17–4.61)

Stage2

70–85

11,552

1958(21.72)

8.02(7.02–9.17)

5.27(4.80–5.79)

3589(39.81)

5.28(4.86–5.73)

3.94(3.70–4.21)

Stage3

70–85

5,284

1026(25.11)

6.23(5.25–7.39)

4.63(4.09–5.25)

1816(44.44)

4.69(4.18–5.25)

3.67(3.36–4.01)

Stage1

age(continuous)

35,478

3454(11.81)

1.19(1.18–1.19)

1.18(1.17–1.19)

7011(23.96)

1.15(1.14–1.15)

1.14(1.14–1.15)

Stage2

22,032

2200(12.36)

1.18(1.17–1.18)

1.17(1.16–1.18)

4260(23.93)

1.14(1.14–1.15)

1.14(1.13–1.14)

Stage3

9577

1177(15.18)

1.16(1.15–1.17)

1.15(1.14–1.16)

2170(27.98)

1.13(1.13–1.14)

1.13(1.12–1.14)